| 标题 |
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet (London, England) 作者:Rosenstock J; Wysham C; Frías JP; Kaneko S; Lee CJ; et al 出版日期:2021/07/10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)